Transforming Infectious Disease Diagnostics with tNGS Technology

In the world of modern diagnostics, speed, accuracy, and comprehensiveness are critical—especially when dealing with complex infections. The latest advancements in targeted next-generation sequencing (tNGS) are redefining how laboratories detect pathogens and manage antimicrobial resistance (AMR).

At the core of this innovation is HyPA (Hyperplex Precise Amplification) technology, which combines multiplex PCR with next-generation sequencing. This powerful approach enables the detection of hundreds of pathogens—including bacteria, viruses, fungi, and parasites—from a single sample. Even more importantly, it identifies drug-resistance and virulence genes, helping clinicians make precise treatment decisions faster.

One of the biggest advantages of this system is its efficiency. Traditional diagnostic methods, such as culture testing, can take days or even weeks. In contrast, this integrated workflow delivers actionable results in under 10 hours—from sample preparation to AI-assisted reporting. This speed is crucial in critical care settings like ICUs, where early intervention can significantly improve patient outcomes.

The technology also stands out for its broad coverage. With the ability to detect up to 475 pathogens and 88 antimicrobial resistance genes in a single run, it provides a comprehensive view of infections, including co-infections that are often missed by conventional tests. This is especially valuable for conditions like tuberculosis, fungal infections, and hospital-acquired infections.

Another key highlight is its role in combating the global AMR crisis. By rapidly identifying resistance genes, clinicians can move away from empirical treatments and adopt targeted therapies, improving patient care while reducing the misuse of antibiotics.

In addition, the system is designed with usability in mind. With automated workflows, integrated sequencing platforms, and AI-driven bioinformatics, even laboratories with limited sequencing experience can adopt this technology.

As infectious diseases become more complex and resistance patterns continue to evolve, advanced solutions like tNGS are no longer optional—they are essential. By combining speed, precision, and scalability, this new generation of diagnostics is setting a new standard for healthcare worldwide.

Flyer for Transforming Infectious Disease Diagnostics with tNGS Technology